Non-Invasive Prenatal Diagnosis of Multiple Endocrine Neoplasia Type 2A Using COLD-PCR Combined with HRM Genotyping Analysis from Maternal Serum

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Macher, Hada C ^a   Martinez Broca, Maria A ^a   Rubio Calvo, Amalia ^a   Leon Garcia, Cristina ^a   Conde Sanchez, Manuel ^a   Costa, Alzenira ^a   Navarro, Elena ^a   Guerrero, Juan M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN RET;

ARTICLE; BLOOD SAMPLING; C RET GENE; CLINICAL ARTICLE; COAMPLIFICATION AT LOWER DENATURATION TEMPERATURE POLYMERASE CHAIN REACTION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FETUS; FETUS OUTCOME; GENE; GENE MUTATION; GENE SEQUENCE; HETEROZYGOTE; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; MEN2A GENE; MUTATIONAL ANALYSIS; NON INVASIVE MEASUREMENT; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SIPPLE SYNDROME;

ADULT; FEMALE; GENOTYPE; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MUTATION; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; PROTO-ONCOGENE PROTEINS C-RET;

EID: 84870944808     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051024     Document Type: Article

References (40)

1. Moline J, Eng C, (2011) Multiple endocrine neoplasia type 2: an overview. Genet Med 13: 755-764.
2. Akerstrom G, Stalberg P, (2009) Surgical management of MEN-1 and-2: state of the art. Surg Clin N Am 89: 1047-1068.
3. Quayle FJ, Fialkowski EA, Benveniste R, Moley JF, (2007) Pheochromocytoma penetrance varies by RET mutation in MEN 2A. Surgery 142: 800-805.
4. Raue F, Kraimps JL, Dralle H, Cougard P, Proye C, et al. (1995) Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Int Med 238: 369-373.
5. Marini F, Falchetti A, DelMonte F, Carbonell-Sala S, Tognarini I, et al. (2006) Multiple endocrine neoplasia type 2. Orphanet J Rare Dis 1: 45.
6. Gagel RF, Melvin KE, Tashjian AH Jr, Miller HH, Feldman ZT, et al. (1975) Natural history of the familial medullary thyroid carcinoma-pheochromocytoma syndrome and the identification of preneoplastic stages by screening studies: a five-year report. Trans Assoc Am Physicians 88: 177-191.
7. Punales MK, Graf H, Gross JL, Maia AL, (2003) RET codon 634 mutations in multiple endocrine neoplasia type 2: variable clinical features and clinical outcome. J Clin Endocrinol Metab 88: 2644-2649.
8. Norbury G, Norbury CJ, (2008) Non-invasive prenatal diagnosis of single gene disorders: How close are we? Semin Fetal Neonatal Med 13: 76-83.
9. Pinzani P, Salvianti F, Pazzagli M, Orlando C, (2010) Circulating nucleic acids in cancer and pregnancy. Methods 50: 302-307.
10. Gormally E, Caboux E, Vineis P, Hainaut P, (2007) Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significance. Mutat Res 635: 105-117.
11. Stroun M, Lyautey J, Lederrey C, Olson-Sand A, Anker P, (2001) About the possible origin and mechanism of circulating DNA: Apoptosis and active DNA release. Clin Chim Acta 313: 139-142.
12. García-Olmo DC, Ruiz-Piqueras R, García-Olmo D, (2004) Circulating nucleic acids in plasma and serum (CNAPS) and its relation to stem cells and cancer metastasis: State of the issue. Histol Histopathol 19: 575-583.
13. García-Olmo D, García-Olmo DC, (2001) Functionality of circulating DNA: The hypothesis of genometastasis. Ann NY Acad Sci 945: 265-275.
14. Schwarzenbach H, Alix-Panabières C, Müller I, Letang N, Vendrell JP, et al. (2009) Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer. Clin Cancer Res 153: 1032-1038.
15. Chiu RWK, Lo YMD, (2011) Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age. Semin Fetal Neonatal Med 16: 88-93.
16. Lo YMD, Tein MSC, Lau TK, Haines CJ, Leung TN, et al. (1998) Quantitative Analysis of Fetal DNA in Maternal Plasma and Serum: Implications for Noninvasive Prenatal Diagnosis. Am J Hum Genet 62: 768-775.
17. Lun FMF, Chiu RWK, Chan KCA, Leung TK, Lau TK, et al. (2008) Microfluidics Digital PCR Reveals a Higher than Expected Fraction of Fetal DNA in Maternal Plasma. Clin Chem 54: 1664-1672.
18. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, et al. (1999) Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 64: 218-224.
19. Milbury CA, Li J, Makrigiorgos GM, (2009) COLD-PCR-Enhanced High-Resolution Melting Enables Rapid and Selective Identification of Low-Level Unknown Mutations. Clin Chem 55: 2130-2143.
20. Li J, Wang L, Mamon H, Kulke MH, Berbeco R, et al. (2008) Replacing PCR with COLDPCR enriches variant DNA sequences and redefines the sensitivity of genetic testing. Nat Med 14: 579-584.
21. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, et al. (2001) DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61: 1659-1665.
22. Zhong XY, von Muhlenen I, Li Y, Kang A, Gupta AK, et al. (2007) Increased concentrations of antibody-bound circulatory cell-free DNA in rheumatoid arthritis. Clin Chem 53: 1609-1614.
23. Rainer TH, Wong LK, Lam W, Yuen E, Lam NY, et al. (2003) Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem 49: 562-569.
24. Antonatos D, Patsilinakos S, Spanodimos S, Korkonikitas P, Tsigas D, (2006) Cell-free DNA levels as a prognostic marker in acute myocardial infarction. Ann N Y Acad Sci 1075: 278-281.
25. Macher HC, Egea-Guerrero JJ, Revuelto-Rey J, Gordillo-Escobar E, Enamorado-Enamorado J, et al. (2012) Role of early cell-free DNA levels decrease as a predictive marker of fatal outcome after severe traumatic brain injury. Clin Chim Acta 414: 12-17.
26. Garci{dotless}a-Moreira V, Prieto-Garci{dotless}a B, Baltar-Marti{dotless}n JM, Ortega-Suarez F, Alvarez FV, (2009) Cell-free DNA as a noninvasive acute rejection marker in renal transplantation. Clin Chem 55: 1958-1966.
27. Garci{dotless}a-Moreira V, de la Cera-Marti{dotless}nez T, Gago-Gonzalez E, Prieto-Garci{dotless}a B, Alvarez-Menendez FV, (2008) Increase in and clearance of cell-free plasma DNA in hemodialysis quantified by real-time PCR. Clin Chem Lab Med 44: 1410-1415.
28. Saukkonen K, Lakkisto P, Pettila V, Varpula M, Karlsson S, et al. (2008) Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock. Clin Chem 54: 1000-1007.
29. Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, et al. (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350: 485-487.
30. Illanes S, Denbow M, Kailasam C, Finning K, Soothill PW, (2007) Early detection of cell-free fetal DNA in maternal plasma. Early Hum Dev 83: 563-566.
31. Macher HC, Noguerol P, Medrano-Campillo P, Garrido-Márquez MR, Rubio-Calvo A, et al. (2012) Standardization non-invasive fetal RHD and SRY determination into clinical routine using a new multiplex RT-PCR assay for fetal cell-free DNA in pregnant women plasma: Results in clinical benefits and cost saving. Clin Chim Acta 413: 490-494.
32. Finning K, Martin P, Summers J, Massey E, Poole G, et al. (2008) Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. Br Med J 336: 816-818.
33. Minon JM, Gerard C, Senterre JM, Schaaps JP, Foidart JM, (2008) Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium. Transfusion 48: 373-381.
34. Lo YMD, Lun FMF, Chan KCA, Tsui NBY, Chong KC, et al. (2007) From the cover: digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci USA 104: 13116-13121.
35. Wright CF, Burton H, (2009) The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Human Reprod Update 15: 139-151.
36. Margraf RL, Mao R, Highsmith WE, Holtegaard LM, Wittwer CT, (2006) Mutation scanning of the RET protooncogene using High-Resolution Melting analysis. Clin Chem 52: 138-141.
37. Reed GH, Wittwer CT, (2004) Sensitivity and specificity of single-nucleotide polymorphism scanning by high-resolution melting analysis. Clin Chem 50: 1748-1754.
38. Loeb LA, Loeb KR, Anderson JP, (2003) Multiple mutations and cancer. Proc Nat Acad Sci USA 100: 776-781.
39. Ogino S, Kawasaki T, Brahmandam M, Yan L, Cantor M, et al. (2005) Sensitive sequencing method for KRAS mutation detection by pyrosequencing. J Mol Diag 7: 413-421.
40. Milbury CA, Li J, Liu P, Makrigiorgos GM, (2011) COLD-PCR: Improving the sensitivity of molecular diagnostics assays. Expert Rev Mol Diagn 11: 159-169.